![]() |
**__Related stories:__***linkurl:Expert advice on surviving $ mess;https://www.the-scientist.com/blog/display/55191/
[13th November 2008]*linkurl:Chasing Challenges;https://www.the-scientist.com/2008/9/1/69/1/
[September 2008]
Drug maker AstraZeneca is pink-slipping approximately 550 Wilmington, Delaware-based researchers and their support staff in a move to help balance the company's books and save it $1.9 billion per year by 2014. Image: B.gliwa via Wikipedia CommonsThe company told the linkurl:__Philadelphia Inquirer__;https://www.philly.com/philly/business/86127882.html yesterday (March 3rd) that the layoffs are part of a plan to shutter an entire research group, focused on identifying candidate compounds for psyc
![]() |


From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.
View Full Profile

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.
View this Issue
Explore strategies for improving recombinant adeno-associated virus production in transient HEK293 suspension cultures while maintaining vector quality and supporting scalable viral vector manufacturing.


Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.


Bench architecture, primer design, and liquid handling set an assay's limit as throughput climbs.


Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.


European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.

Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development

This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate neurodegenerative disease research.

Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.
